Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • Vascular Malformations (Apr 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact

Citations to this article

FGF23 induces left ventricular hypertrophy
Christian Faul, … , Martin G. Keane, Myles Wolf
Christian Faul, … , Martin G. Keane, Myles Wolf
Published October 10, 2011
Citation Information: J Clin Invest. 2011;121(11):4393-4408. https://doi.org/10.1172/JCI46122.
View: Text | PDF
Research Article Nephrology Article has an altmetric score of 30

FGF23 induces left ventricular hypertrophy

  • Text
  • PDF
Abstract

Chronic kidney disease (CKD) is a public health epidemic that increases risk of death due to cardiovascular disease. Left ventricular hypertrophy (LVH) is an important mechanism of cardiovascular disease in individuals with CKD. Elevated levels of FGF23 have been linked to greater risks of LVH and mortality in patients with CKD, but whether these risks represent causal effects of FGF23 is unknown. Here, we report that elevated FGF23 levels are independently associated with LVH in a large, racially diverse CKD cohort. FGF23 caused pathological hypertrophy of isolated rat cardiomyocytes via FGF receptor–dependent activation of the calcineurin-NFAT signaling pathway, but this effect was independent of klotho, the coreceptor for FGF23 in the kidney and parathyroid glands. Intramyocardial or intravenous injection of FGF23 in wild-type mice resulted in LVH, and klotho-deficient mice demonstrated elevated FGF23 levels and LVH. In an established animal model of CKD, treatment with an FGF–receptor blocker attenuated LVH, although no change in blood pressure was observed. These results unveil a klotho-independent, causal role for FGF23 in the pathogenesis of LVH and suggest that chronically elevated FGF23 levels contribute directly to high rates of LVH and mortality in individuals with CKD.

Authors

Christian Faul, Ansel P. Amaral, Behzad Oskouei, Ming-Chang Hu, Alexis Sloan, Tamara Isakova, Orlando M. Gutiérrez, Robier Aguillon-Prada, Joy Lincoln, Joshua M. Hare, Peter Mundel, Azorides Morales, Julia Scialla, Michael Fischer, Elsayed Z. Soliman, Jing Chen, Alan S. Go, Sylvia E. Rosas, Lisa Nessel, Raymond R. Townsend, Harold I. Feldman, Martin St. John Sutton, Akinlolu Ojo, Crystal Gadegbeku, Giovana Seno Di Marco, Stefan Reuter, Dominik Kentrup, Klaus Tiemann, Marcus Brand, Joseph A. Hill, Orson W. Moe, Makoto Kuro-o, John W. Kusek, Martin G. Keane, Myles Wolf

×

Total citations by year

Year: 2025 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2009 Total
Citations: 20 58 74 87 93 69 85 83 76 66 72 91 84 43 1 1 1003
Citation information
This citation data is accumulated from CrossRef, which receives citation information from participating publishers, including this journal. Not all publishers participate in CrossRef, so this information is not comprehensive. Additionally, data may not reflect the most current citations to this article, and the data may differ from citation information available from other sources (for example, Google Scholar, Web of Science, and Scopus).

Citations to this article in year 2018 (83)

Title and authors Publication Year
Insulin suppresses the production of fibroblast growth factor 23 (FGF23)
L Bär, M Feger, A Fajol, LO Klotz, S Zeng, F Lang, B Hocher, M Föller
Proceedings of the National Academy of Sciences 2018
Fibroblast Growth Factor 23 Associates with Death in Critically Ill Patients
DE Leaf, ED Siew, MF Eisenga, K Singh, FR Causland, A Srivastava, TA Ikizler, LB Ware, AA Ginde, JA Kellum, PM Palevsky, M Wolf, SS Waikar
Clinical journal of the American Society of Nephrology : CJASN 2018
Acute blood loss stimulates fibroblast growth factor 23 production
S Rabadi, I Udo, DE Leaf, SS Waikar, M Christov
American journal of physiology. Renal physiology 2018
Deleting Death and Dialysis: Conservative Care of Cardio-Vascular Risk and Kidney Function Loss in Chronic Kidney Disease (CKD)
R Vanholder, SV Laecke, G Glorieux, F Verbeke, E Castillo-Rodriguez, A Ortiz
Toxins 2018
FGF23 Actions on Target Tissues—With and Without Klotho
B Richter, C Faul
Frontiers in Endocrinology 2018
Cardiotoxicity of Uremic Toxins: A Driver of Cardiorenal Syndrome
S Lekawanvijit
Toxins 2018
Cardiovascular Interactions between Fibroblast Growth Factor-23 and Angiotensin II
M Pi, R Ye, X Han, B Armstrong, X Liu, Y Chen, Y Sun, LD Quarles
Scientific Reports 2018
Effects of sucroferric oxyhydroxide and sevelamer carbonate on chronic kidney disease–mineral bone disorder parameters in dialysis patients
M Ketteler, SM Sprague, AC Covic, A Rastogi, B Spinowitz, V Rakov, S Walpen, J Floege
Nephrology Dialysis Transplantation 2018
The effects of tenapanor on serum fibroblast growth factor 23 in patients receiving hemodialysis with hyperphosphatemia
GA Block, DP Rosenbaum, A Yan, PJ Greasley, GM Chertow, M Wolf
Nephrology Dialysis Transplantation 2018
Use of phosphate-binders and risk of infection-related and all-cause mortality in patients undergoing hemodialysis: The Q-Cohort Study
S Yamada, M Tokumoto, M Taniguchi, H Yoshida, H Arase, N Tatsumoto, H Hirakata, T Kitazono, K Tsuruya
Scientific Reports 2018
Exploring the Clinical Relevance of Providing Increased Removal of Large Middle Molecules
M Wolley, M Jardine, CA Hutchison
Clinical journal of the American Society of Nephrology : CJASN 2018
Fibroblast growth factor 23 does not directly influence skeletal muscle cell proliferation and differentiation or ex vivo muscle contractility
KG Avin, JA Vallejo, NX Chen, K Wang, CD Touchberry, M Brotto, SL Dallas, SM Moe, MJ Wacker
American journal of physiology. Endocrinology and metabolism 2018
Non-renal-Related Mechanisms of FGF23 Pathophysiology
MR Hanudel, M Laster, IB Salusky
Current Osteoporosis Reports 2018
Impaired osteocyte maturation in the pathogenesis of renal osteodystrophy
RC Pereira, IB Salusky, P Roschger, K Klaushofer, O Yadin, EG Freymiller, R Bowen, AM Delany, N Fratzl-Zelman, K Wesseling-Perry
Kidney International 2018
Fibroblast growth factor 23 and α-Klotho co-dependent and independent functions:
LD Quarles
Current Opinion in Nephrology and Hypertension 2018
Inhibition of fibroblast growth factor 23 (FGF23) signaling rescues renal anemia
R Agoro, A Montagna, R Goetz, O Aligbe, G Singh, LM Coe, M Mohammadi, S Rivella, D Sitara
The FASEB Journal 2018
Calcitriol downregulates fibroblast growth factor receptor 1 through histone deacetylase activation in HL-1 atrial myocytes
TW Lee, TI Lee, YK Lin, YH Kao, YJ Chen
Journal of Biomedical Science 2018
Large uremic toxins: an unsolved problem in end-stage kidney disease
MJ Wolley, CA Hutchison
Nephrology Dialysis Transplantation 2018
Effect of combined vitamin D receptor activator and lanthanum carbonate on serum fibroblast growth factor 23 level in predialysis patients (CVD-LAF study): design and method
E Ito, D Inaguma, S Koide, K Takahashi, H Hayashi, M Hasegawa, Y Yuzawa
Clinical and Experimental Nephrology 2018
Cardioprotective Effects of Paricalcitol Alone and in Combination With FGF23 Receptor Inhibition in Chronic Renal Failure: Experimental and Clinical Studies
B Czaya, W Seeherunvong, S Singh, C Yanucil, P Ruiz, Y Quiroz, A Grabner, C Katsoufis, S Swaminathan, C Abitbol, B Rodriguez-Iturbe, C Faul, M Freundlich
American Journal of Hypertension 2018
Effect of Oral Alfacalcidol on Clinical Outcomes in Patients Without Secondary Hyperparathyroidism Receiving Maintenance Hemodialysis: The J-DAVID Randomized Clinical Trial
T Shoji, M Inaba, M Fukagawa, R Ando, M Emoto, H Fujii, A Fujimori, M Fukui, H Hase, T Hashimoto, H Hirakata, H Honda, T Hosoya, Y Ikari, D Inaguma, T Inoue, Y Isaka, K Iseki, E Ishimura, N Itami, C Ito, T Kakuta, T Kawai, H Kawanishi, S Kobayashi, J Kumagai, K Maekawa, I Masakane, J Minakuchi, K Mitsuiki, T Mizuguchi, S Morimoto, T Murohara, T Nakatani, S Negi, S Nishi, M Nishikawa, T Ogawa, K Ohta, T Ohtake, M Okamura, S Okuno, T Shigematsu, T Sugimoto, M Suzuki, H Tahara, Y Takemoto, K Tanaka, Y Tominaga, Y Tsubakihara, Y Tsujimoto, K Tsuruya, S Ueda, Y Watanabe, K Yamagata, T Yamakawa, S Yano, K Yokoyama, N Yorioka, M Yoshiyama, Y Nishizawa
Journal of the American Medical Association 2018
Targeting Fibroblast Growth Factor 23 Signaling with Antibodies and Inhibitors, Is There a Rationale?
S Fukumoto
Frontiers in Endocrinology 2018
Association of Fibroblast Growth Factor 23 With Recurrent Cardiovascular Events in Patients After an Acute Coronary Syndrome: A Secondary Analysis of a Randomized Clinical Trial
BA Bergmark, JA Udell, DA Morrow, CP Cannon, DL Steen, P Jarolim, A Budaj, C Hamm, J Guo, KA Im, JF Kuder, E Braunwald, MS Sabatine, ML ODonoghue
JAMA Cardiology 2018
Physiological Actions of Fibroblast Growth Factor-23
RG Erben
Frontiers in Endocrinology 2018
Fibroblast growth factor 23 is upregulated in the kidney in a chronic kidney disease rat model
H Sugiura, A Matsushita, M Futaya, A Teraoka, K Akiyama, N Usui, N Nagano, K Nitta, K Tsuchiya, N Ashton
PloS one 2018
A high-fat diet stimulates fibroblast growth factor 23 formation in mice through TNFα upregulation
P Glosse, A Fajol, F Hirche, M Feger, J Voelkl, F Lang, GI Stangl, M Föller
Nutrition and Diabetes 2018
Elevated FGF23 Levels in Mice Lacking the Thiazide-Sensitive NaCl cotransporter (NCC)
G Pathare, M Anderegg, G Albano, F Lang, DG Fuster
Scientific Reports 2018
Effects of erythropoietin on fibroblast growth factor 23 in mice and humans
MR Hanudel, MF Eisenga, M Rappaport, K Chua, B Qiao, G Jung, V Gabayan, B Gales, G Ramos, MA de Jong, JJ van Zanden, MH de Borst, SJ Bakker, E Nemeth, IB Salusky, CA Gaillard, T Ganz
Nephrology Dialysis Transplantation 2018
The Klotho proteins in health and disease
M Kuro-o
Nature Reviews Nephrology 2018
Crosstalk between FGF23- and angiotensin II-mediated Ca2+ signaling in pathological cardiac hypertrophy
KN Mhatre, P Wakula, O Klein, E Bisping, J Völkl, B Pieske, FR Heinzel
Cellular and Molecular Life Sciences 2018
Hyperphosphatemic familial tumoral calcinosis secondary to fibroblast growth factor 23 (FGF23) mutation: a report of two affected families and review of the literature
M Chakhtoura, MS Ramnitz, N Khoury, G Nemer, N Shabb, A Abchee, A Berberi, M Hourani, M Collins, S Ichikawa, GE Fuleihan
Osteoporosis International 2018
Paracrine Effects of FGF23 on the Heart
M Leifheit-Nestler, D Haffner
Frontiers in Endocrinology 2018
Impact of Altered Mineral Metabolism on Pathological Cardiac Remodeling in Elevated Fibroblast Growth Factor 23
M Leifheit-Nestler, B Richter, M Basaran, J Nespor, I Vogt, I Alesutan, J Voelkl, F Lang, J Heineke, S Krick, D Haffner
Frontiers in Endocrinology 2018
Telomere Homeostasis: Interplay with Magnesium
D Maguire, O Neytchev, D Talwar, D McMillan, P Shiels
International journal of molecular sciences 2018
The Ebb and Flow of Echocardiographic Cardiac Function Parameters in Relationship to Hemodialysis Treatment in Patients with ESRD
C Loutradis, PA Sarafidis, CE Papadopoulos, A Papagianni, C Zoccali
Journal of the American Society of Nephrology : JASN 2018
Fibroblast Growth Factor 23: A Biomarker of Kidney Function Decline
DA Drew, R Katz, S Kritchevsky, JH Ix, MG Shlipak, AB Newman, A Hoofnagle, L Fried, MJ Sarnak, OM Gutierrez
American Journal of Nephrology 2018
Increased Circulating FGF23 Does Not Lead to Cardiac Hypertrophy in the Male Hyp Mouse Model of XLH
ES Liu, R Thoonen, E Petit, B Yu, ES Buys, M Scherrer-Crosbie, MB Demay
Endocrinology 2018
Sleep disordered breathing and fibroblast growth factor 23 in the Hispanic Community Health Study/Study of Latinos
R Mehta, X Cai, A Hodakowski, B Thyagarajan, D Zeng, PC Zee, WK Wohlgemuth, S Redline, JP Lash, M Wolf, T Isakova
Bone 2018
Vitamin D and kidney disease
L Keung, F Perwad
Bone Reports 2018
Vitamin D and Calcimimetics in Cardiovascular Disease
K Lim, T Hamano, R Thadhani
Seminars in Nephrology 2018
Phosphate is a potential biomarker of disease severity and predicts adverse outcomes in acute kidney injury patients undergoing continuous renal replacement therapy
SY Jung, J Kwon, S Park, JH Jhee, HR Yun, HN Kim, YK Kee, CY Yoon, TI Chang, EW Kang, JT Park, TH Yoo, SW Kang, SH Han, YR Kou
PloS one 2018
Cisplatin nephrotoxicity as a model of chronic kidney disease
M Shi, KL McMillan, J Wu, N Gillings, B Flores, OW Moe, MC Hu
Laboratory Investigation 2018
The Role of Cardiokines in Heart Diseases: Beneficial or Detrimental?
YS Wu, B Zhu, AL Luo, L Yang, C Yang
BioMed Research International 2018
FGF23 in Cardiovascular Disease: Innocent Bystander or Active Mediator?
R Stöhr, A Schuh, GH Heine, V Brandenburg
Frontiers in Endocrinology 2018
Outcome Prediction of Acute Kidney Injury Biomarkers at Initiation of Dialysis in Critical Units
VC Wu, CC Shiao, NH Chi, CH Wang, SC Chueh, HH Liou, H Spapen, PM Honore, TS Chu
Journal of Clinical Medicine 2018
Dietary Phosphorus and Ambulatory Blood Pressure in African Americans: The Jackson Heart Study
RE Olivo, SL Hale, CJ Diamantidis, NA Bhavsar, CC Tyson, KL Tucker, TC Carithers, B Kestenbaum, P Muntner, RM Tanner, JN Booth, SE Mwasongwe, J Pendergast, LE Boulware, JJ Scialla
American Journal of Hypertension 2018
Uremic Cardiomyopathy: A New Piece in the Chronic Kidney Disease-Mineral and Bone Disorder Puzzle
PG de Albuquerque Suassuna, H Sanders-Pinheiro, RB de Paula
Frontiers in Medicine 2018
Fibroblast Growth Factor 23 is Associated With Adiposity in Patients Receiving Hemodialysis: Possible Cross Talk Between Bone and Adipose Tissue
JM Chiang, GA Kaysen, AL Schafer, C Delgado, KL Johansen
Journal of renal nutrition : the official journal of the Council on Renal Nutrition of the National Kidney Foundation 2018
Evidence basis for integrated management of mineral metabolism in patients with end-stage renal disease:
JJ Scialla
Current Opinion in Nephrology and Hypertension 2018
Fibroblast growth factor23 is associated with axonal integrity and neural network architecture in the human frontal lobes
BK Marebwa, RJ Adams, GS Magwood, M Kindy, J Wilmskoetter, M Wolf, L Bonilha, BC Bernhardt
PloS one 2018
Chronic kidney disease as a cardiovascular risk factor: lessons from kidney donors
AM Price, NC Edwards, MK Hayer, WE Moody, RP Steeds, CJ Ferro, JN Townend
Journal of the American Society of Hypertension : JASH 2018
Markers of vitamin D metabolism and incidence of clinically diagnosed abdominal aortic aneurysm: The Atherosclerosis Risk in Communities Study
PL Lutsey, MR Rooney, AR Folsom, ED Michos, A Alonso, W Tang
Vascular medicine (London, England) 2018
Clinical experience with the use of ferric citrate as a phosphate binder in pediatric dialysis patients
MR Hanudel, M Laster, G Ramos, B Gales, IB Salusky
Pediatric Nephrology 2018
Uremic Toxins and Clinical Outcomes: The Impact of Kidney Transplantation
S Liabeuf, L Cheddani, Z Massy
Toxins 2018
High Fibroblast Growth Factor 23 concentrations in experimental renal failure impair calcium handling in cardiomyocytes
M Verkaik, M Oranje, D Abdurrachim, M Goebel, Z Gam, JJ Prompers, M Helmes, PM ter Wee, J van der Velden, DW Kuster, MG Vervloet, EC Eringa
Physiological Reports 2018
Waist-to-height ratio, body mass index, and cardiovascular risk profile in children with chronic kidney disease
K Sgambat, J Roem, M Mitsnefes, AA Portale, S Furth, B Warady, A Moudgil
Pediatric Nephrology 2018
Klotho is upregulated in human cardiomyopathy independently of circulating Klotho levels
G Poelzl, SK Ghadge, M Messner, B Haubner, P Wuertinger, A Griesmacher, J Doerler, C Ensinger, H Ulmer, MM Zaruba
Scientific Reports 2018
Vascular Calcification in Chronic Kidney Disease: The Role of Inflammation
K Benz, KF Hilgers, C Daniel, K Amann
International Journal of Nephrology 2018
Phosphate and Cardiovascular Disease beyond Chronic Kidney Disease and Vascular Calcification
S Disthabanchong
International Journal of Nephrology 2018
Role of etelcalcetide in the management of secondary hyperparathyroidism in hemodialysis patients: a review on current data and place in therapy
C Friedl, E Zitt
Drug design, development and therapy 2018
Fibroblast Growth Factor-23 and Risks of Cardiovascular and Noncardiovascular Diseases: A Meta-Analysis
A Marthi, K Donovan, R Haynes, DC Wheeler, C Baigent, CM Rooney, MJ Landray, SM Moe, J Yang, L Holland, R di Giuseppe, AB Krijger, B Mihaylova, WG Herrington
Journal of the American Society of Nephrology : JASN 2018
Acute Kidney Injury and Risk of Heart Failure and Atherosclerotic Events
AS Go, C Hsu, J Yang, TC Tan, S Zheng, JD Ordonez, KD Liu
Clinical journal of the American Society of Nephrology : CJASN 2018
Fibroblast growth factor 23 and Klotho contribute to airway inflammation
S Krick, A Grabner, N Baumlin, C Yanucil, S Helton, A Grosche, J Sailland, P Geraghty, L Viera, DW Russell, JM Wells, X Xu, A Gaggar, J Barnes, GD King, M Campos, C Faul, M Salathe
The European respiratory journal : official journal of the European Society for Clinical Respiratory Physiology 2018
Changes in Biomarker Profile and Left Ventricular Hypertrophy Regression: Results from the Frequent Hemodialysis Network Trials
CT Chan, GA Kaysen, GJ Beck, M Li, J Lo, MV Rocco, AS Kliger
American Journal of Nephrology 2018
Fibroblast Growth Factor‐23 and Heart Failure With Reduced Versus Preserved Ejection Fraction: MESA
MF Almahmoud, EZ Soliman, AG Bertoni, B Kestenbaum, R Katz, JA Lima, P Ouyang, PE Miller, ED Michos, DM Herrington
Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease 2018
Intestinal Phosphorus Absorption in Chronic Kidney Disease
E Stremke, KH Gallant
Nutrients 2018
Serum NGAL and FGF23 may have certain value in early diagnosis of CIN
H Li, Z Yu, L Gan, L Peng, Q Zhou
Renal Failure 2018
Cardiovascular disease in dialysis patients
M Cozzolino, M Mangano, A Stucchi, P Ciceri, F Conte, A Galassi
Nephrology Dialysis Transplantation 2018
Letter to the Editor: “Increased Circulating FGF23 Does Not Lead to Cardiac Hypertrophy in the Male Hyp Mouse Model of XLH”
X Han, LD Quarles
Endocrinology 2018
Left Ventricular Structure in Patients With Mild-to-Moderate CKD—a Magnetic Resonance Imaging Study
MP Schneider, JB Scheppach, U Raff, S Toncar, C Ritter, T Klink, S Störk, C Wanner, G Schlieper, T Saritas, SD Reinartz, J Floege, N Friedrich, R Janka, M Uder, RE Schmieder, KU Eckardt
Kidney International Reports 2018
Update on Chronic Kidney Disease Mineral and Bone Disorder in Cardiovascular Disease
J Lunyera, JJ Scialla
Seminars in Nephrology 2018
Quantitative Gadolinium-Free Cardiac Fibrosis Imaging in End Stage Renal Disease Patients Reveals A Longitudinal Correlation with Structural and Functional Decline
TA Stromp, TJ Spear, RM Holtkamp, KN Andres, JC Kaine, WH Alghuraibawi, SW Leung, BK Fornwalt, MH Vandsburger
Scientific Reports 2018
FGF23 Induction of O-Linked N-Acetylglucosamine Regulates IL-6 Secretion in Human Bronchial Epithelial Cells
S Krick, ES Helton, SB Hutcheson, S Blumhof, JM Garth, RS Denson, RS Zaharias, H Wickham, JW Barnes
Frontiers in Endocrinology 2018
Changes in serum and intracardiac fibroblast growth factor 23 during the progression of left ventricular hypertrophy in hypertensive model rats
H Fujii, K Watanabe, K Kono, S Goto, S Watanabe, S Nishi
Clinical and Experimental Nephrology 2018
PTH, FGF23, and Intensive Blood Pressure Lowering in Chronic Kidney Disease Participants in SPRINT
C Ginsberg, TE Craven, MB Chonchol, AK Cheung, MJ Sarnak, WT Ambrosius, AA Killeen, KL Raphael, UY Bhatt, J Chen, GM Chertow, BI Freedman, S Oparil, V Papademetriou, BM Wall, CB Wright, J H., MG Shlipak
Clinical journal of the American Society of Nephrology : CJASN 2018
Cardiovascular Events after New-Onset Atrial Fibrillation in Adults with CKD: Results from the Chronic Renal Insufficiency Cohort (CRIC) Study
N Bansal, D Xie, D Sha, LJ Appel, R Deo, HI Feldman, J He, K Jamerson, JW Kusek, S Messe, SD Navaneethan, M Rahman, AC Ricardo, EZ Soliman, R Townsend, AS Go
Journal of the American Society of Nephrology : JASN 2018
Lack of Awareness of Dietary Sources of Phosphorus Is a Clinical Concern
M Shimada, Y Shutto-Uchita, H Yamabe
In vivo (Athens, Greece) 2018
Active Vitamin D in Chronic Kidney Disease: Getting Right Back Where We Started from?
L Negrea
Kidney Diseases 2018
Association of Fibroblast Growth Factor 23 With Risk of Incident Coronary Heart Disease in Community-Living Adults
B Panwar, SE Judd, VG Wadley, NS Jenny, VJ Howard, MM Safford, OM Gutiérrez
JAMA Cardiology 2018
Managing hyperparathyroidism in hemodialysis: role of etelcalcetide
KE Eidman, JB Wetmore
International journal of nephrology and renovascular disease 2018
Summary of the 2018 ISN Frontiers Meeting: Kidney Disease and Cardiovascular Disease
Kume S, Nagasu H, Nangaku M, Nishiyama A, Nakamoto H, Kashihara N
Kidney International Reports 2018
Effects of parathyroidectomy on blood bone markers and heart rate variability in patients with stage 5 chronic kidney disease.
Chen H, Cui Y, Xing C, Purrunsing Y, Zha X, Shen C, Zeng M, Yang G, Yu X, Zhang L, Jiang Y, Shen Z, Ma H, Yin C, Li Y, Wang N
International Urology and Nephrology 2018
Comparison of echocardiographic changes in children with primary hypertension and hypertension due to mild to moderate chronic kidney disease.
Paris G, Gorla SR, Arenas-Morales AJ, Seeherunvong W, Swaminathan S
Pediatric nephrology (Berlin, Germany) 2018

← Previous 1 2 3 4 Next →

Advertisement

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts

Blogged by 1
Posted by 8 X users
Referenced in 17 patents
Referenced in 6 Wikipedia pages
Highlighted by 1 platforms
Referenced in 1 clinical guideline sources
652 readers on Mendeley
1 readers on CiteULike
See more details